American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology) and Part II: Interactive Case: Critical Evaluation of Kidney Function - 2023 October


Format to Purchase:
Member Price:
$29.95
Nonmember Price:
$29.95

Available for ACPE CREDIT ONLY

 

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP).

Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology)
This feature was developed from a live program presented in October 2022 at the ACCP Global Conference in San Francisco..
  • Recorded Webcast: Click here to access the Recorded webcast.
  • PDF Transcript: Click here to access the PDF Transcript.
Disclosures
Nothing to disclose: Craig J. Beavers, Candace Bryant, Stormi E. Gale, Stephanie Dwyer Kaluzna, A. Joshua Roberts, Kelly M. Rudd

 

Part II: Interactive Case: Critical Evaluation of Kidney Function
This feature was developed from an interactive case presented in PSAP 2023 Book 1 (Endocrinology and Nephrology).
  • Interactive Case: Click here to access the case series.
Disclosures
Consultancies: Wendy St. Peter (Glaxosmithkline)
Nothing to disclose: Ayesha M. Khan, Bryn Lindley, Gary D. Peksa
Release Date: October 08, 2023
BCPS Deadline: April 08, 2024
ACPE Deadline: October 08, 2026

Publication Year: 2023
Format: Online Test

Technical Requirements:

Contents

Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology)

Part II: Interactive Case: Critical Evaluation of Kidney Function

Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology)

Faculty

Craig J. Beavers, Pharm.D., FCCP, FACC, FAHA, BCCP, BCPS-AQ Cardiology, CACP
Director of Cardiovascular Services
Baptist Health Paducah
Cardiovascular Clinical Pharmacist
Department of Pharmacy Services
UK Healthcare
Assistant Adjunct Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Paducah, Kentucky
Kelly M. Rudd, Pharm.D., FCCP, BCPS
Clinical Associate Professor
Oklahoma State University Center for Health Sciences
Tulsa, Oklahoma
Clinical Pharmacist, Anticoagulation
Claremore Indian Hospital
Claremore, Oklahoma
Stephanie Dwyer Kaluzna, Pharm.D., BCCP
Clinical Assistant Professor
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Sciences System
Chicago, Illinois

Reviewers

Stormi E. Gale, Pharm.D., BCPS, BCCP
Clinical Pharmacist, Cardiology Subject Matter Expert
Novant Health Matthews Medical Center
Matthews, North Carolina
Candace Bryant, Pharm.D., BCPS, CACP
Lipscomb University
Nashville, Tennessee
Aaron Joshua Roberts, Pharm.D., BCCP, BCPS-AQ Cardiology, AACC
Pharmacist Specialist - Cardiology
University of California, Davis Health
Sacramento, California

Part II: Interactive Case: Critical Evaluation of Kidney Function

Faculty

Ayesha M. Khan Thelen, Pharm.D., BCPS
Associate Director, Clinical Services
La Grange, Illinois
Gary D. Peksa, Pharm.D., MBA, BCPS
Clinical Specialist, Emergency Medicine
Rush University Medical Center
Chicago, Illinois

Reviewers

Wendy L. St. Peter, Pharm.D.
Professor
University of Minnesota
College of Pharmacy
Minneapolis, Minnesota
Bryn Lindley, Pharm.D., BCPS
Assistant Professor
Department of Pharmacotherapy
University of North Texas Health Science Center
College of Pharmacy
Fort Worth, Texas

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience: Pharmacotherapy specialists and advanced level clinical pharmacists whose practice involves the direct care and management of patients living with one or more common cardiac conditions or disorders.

Contents

Part I: PSAP Live: Updates from 2022 Book 1 (Cardiology)

Activity Number: 0217-0000-23-152-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives
  1. Distinguish the incidence, pathophysiology, risk factors, and clinical presentation associated with heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).
  2. Examine the clinical efficacy and safety data associated with agents recommended for the treatment of HFpEF.
  3. Develop a pharmacologic treatment plan for HFrEF and HFpEF that optimizes the use of guideline-directed medical therapy.
  4. Distinguish the thrombotic pathophysiology of antiphospholipid syndrome (APS).
  5. Evaluate available evidence pertaining to the use of anticoagulants in patients with APS.
  6. Develop an appropriate guideline-driven pharmacotherapeutic treatment plan for a patient with APS.
  7. Design an antithrombotic treatment plan for a patient undergoing coronary stenting.
  8. Analyze recent literature surrounding modified regimens of dual antiplatelet therapy in patients with coronary artery disease and acute coronary syndromes.
  9. Distinguish between the various antithrombotic treatment regimens indicated for patients undergoing transcatheter aortic valve implantation.

Part II: Interactive Case: Critical Evaluation of Kidney Function

Activity Number: 0217-0000-23-153-H01-P
Contact Hour(s): 1.50
Activity Type: Application Based
Learning Objectives
  1. Assess different methods in evaluating kidney function.
  2. Develop patient care plans that equitably and safely address patients with kidney dysfunction.
  3. Evaluate the influence of patient-specific factors on drug disposition.
  4. Distinguish factors that must be considered when designing a drug dosing regimen for a patient with kidney impairment.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.